Literature DB >> 15331815

Pediatric mortality in Africa: plasmodium falciparum malaria as a cause or risk?

Robert W Snow1, Eline L Korenromp, Eleanor Gouws.   

Abstract

The disability adjusted life year (DALY) approach of defining cause-specific health burdens is becoming the benchmark for international disease control prioritization. For malaria, this categorical approach may not fully capture its burden that includes chronic anemia, low birth weight, and enhancement of the severity of other childhood diseases. We investigated the extent to which malaria acts as a risk factor for all-cause mortality in African children less than five years of age from 1) ecologic associations between Plasmodium falciparum infection prevalence (PR) and under-five mortality, and 2) reductions in all-cause under-five mortality achieved in malaria intervention trials. Across 48 demographic surveillance studies, when adjusted for secular trends, PR more than doubled all-cause mortality (P = 0.0001). Trials of insecticide-treated mosquito nets generally found smaller population-attributable fractions of pediatric mortality to malaria infection, which may relate to their imperfect coverage and efficacy. In conclusion, the disability and death burden due to malaria in African children could be higher than that detectable from cause-specific DALY estimations. Copyright 2004 The American Society of Tropical Medicine and Hygiene

Entities:  

Mesh:

Year:  2004        PMID: 15331815

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  33 in total

Review 1.  Vaccines for preventing malaria (SPf66).

Authors:  P Graves; H Gelband
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  The implementation of malaria intermittent preventive trialtreatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control.

Authors:  Alassane Dicko; Moussa Konare; Djibril Traore; Jean Testa; Roger Salamon; Ogobara Doumbo; Christophe Rogier
Journal:  Malar J       Date:  2012-03-16       Impact factor: 2.979

3.  Why the increase in under five mortality in Uganda from 1995 to 2000? A retrospective analysis.

Authors:  Fred Nuwaha; Juliet Babirye; Natal Ayiga
Journal:  BMC Public Health       Date:  2011-09-25       Impact factor: 3.295

Review 4.  The burden of malaria mortality among African children in the year 2000.

Authors:  Alexander K Rowe; Samantha Y Rowe; Robert W Snow; Eline L Korenromp; Joanna Rm Armstrong Schellenberg; Claudia Stein; Bernard L Nahlen; Jennifer Bryce; Robert E Black; Richard W Steketee
Journal:  Int J Epidemiol       Date:  2006-02-28       Impact factor: 7.196

Review 5.  Urbanization, malaria transmission and disease burden in Africa.

Authors:  Simon I Hay; Carlos A Guerra; Andrew J Tatem; Peter M Atkinson; Robert W Snow
Journal:  Nat Rev Microbiol       Date:  2005-01       Impact factor: 60.633

Review 6.  Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa.

Authors:  Helen L Guyatt; Robert W Snow
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Parasite burden and severity of malaria in Tanzanian children.

Authors:  Bronner P Gonçalves; Chiung-Yu Huang; Robert Morrison; Sarah Holte; Edward Kabyemela; D Rebecca Prevots; Michal Fried; Patrick E Duffy
Journal:  N Engl J Med       Date:  2014-05-08       Impact factor: 91.245

Review 8.  Malaria's indirect contribution to all-cause mortality in the Andaman Islands during the colonial era.

Authors:  G Dennis Shanks; Simon I Hay; David J Bradley
Journal:  Lancet Infect Dis       Date:  2008-07-01       Impact factor: 25.071

9.  Malaria prevention in Sub-Saharan Africa: a field study in rural Uganda.

Authors:  Phoebe C M Williams; Alan Martina; Robert G Cumming; John Hall
Journal:  J Community Health       Date:  2009-08

10.  Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum.

Authors:  Aziza Akaddar; Cécile Doderer-Lang; Melissa R Marzahn; François Delalande; Marc Mousli; Karen Helle; Alain Van Dorsselaer; Dominique Aunis; Ben M Dunn; Marie-Hélène Metz-Boutigue; Ermanno Candolfi
Journal:  Cell Mol Life Sci       Date:  2009-12-31       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.